Related Experiment Videos
New tumor antigens recognized by T cells
B Van den Eynde1, V G Brichard
1Ludwig Institute for Cancer Research, Brussels, Belgium.
Current Opinion in Immunology
|October 1, 1995
Summary
This year, researchers identified tumor antigens recognized by cytolytic T lymphocytes. These include tumor-specific proteins, melanocytic differentiation proteins, and mutation-derived antigens unique to individual cancers.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Cytolytic T lymphocytes play a crucial role in anti-tumor immunity.
- Understanding tumor antigens is key to developing effective cancer immunotherapies.
- Tumor antigens can originate from various sources, influencing immune recognition.
Purpose of the Study:
- To characterize tumor cell antigens recognized by cytolytic T lymphocytes.
- To delineate the origins of identified tumor antigens, including differentiation and mutation-derived antigens.
Main Methods:
- Characterization of tumor cell antigens.
- Analysis of antigen sources: tumor-specific proteins, melanocytic differentiation proteins, and mutation-derived antigens.
Main Results:
- A series of tumor antigens recognized by cytolytic T lymphocytes were characterized.
- Identified antigens include those from tumor-specific proteins.
- Melanoma antigens derived from melanocytic differentiation proteins were identified.
- Antigens unique to individual tumors resulting from gene mutations were also characterized.
Conclusions:
- Tumor antigen repertoire is diverse, encompassing self-proteins, differentiation antigens, and neoantigens.
- This characterization provides insights into T cell-mediated tumor recognition.
- Findings contribute to the development of targeted immunotherapies for various cancers, particularly melanoma.